[ad_1]
Several critical advances this month will go a long way toward making obesity drugs more widely available to patients: more consistent access, improved affordability and global conviction that these potentially lifelong treatments are worth the cost to the health-care system.
Resolving those issues matter at both the individual level — enabling people to take drugs that could ultimately save their lives — and the societal one, delivering those treatments without bankrupting the health-care system.
[ad_2]
Source link